Nayara secures £387k in pre-seed funding led by SFC Capital for healthcare artificial intelligence companions
The pre-seed investment will drive product development, clinical validation and commercial expansion.
Nayara develops clinical-grade artificial intelligence companions that support patients between hospital appointments and help ease workloads for healthcare professionals.
London-based healthcare artificial intelligence firm Nayara has closed a pre-seed funding round of £387.9k. The investment was led by SFC Capital, one of the country's most active early-stage investors.
Nayara addresses the gap in patient care outside clinical settings by offering artificial intelligence companions that handle routine enquiries, provide personalised guidance and monitor patient progress. The technology routes critical concerns to healthcare providers, helping overstretched teams prioritise follow-up care.
The proceeds from the financing will be directed towards accelerating product development, securing clinical validation and expanding commercial operations.
From the founder
"We started Nayara with a simple belief: no patient should feel alone in their healthcare journey. No warning sign should go unaddressed because the clinical team lacked the information, or the time, to act."
Gal Moore
Co-Founder and CEO at Nayara
Investor perspective
"We see tremendous potential in Nayara’s vision and the team’s ability to execute. As healthcare systems face mounting pressure, solutions that can deliver meaningful improvements for both patients and providers represent an exciting investment opportunity. We’re delighted to support Nayara in its next stage of growth."
Adam Beveridge
Fund Principal, SFC
Use of funds
- 01Continue product development
- 02Fund research and development
- 03Accelerate go-to-market
Investors
.png)
Categories
About the company
Nayara
Nayara provides clinical-grade artificial intelligence companions to extend patient care beyond the hospital setting.